BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 15369356)

  • 1. Artificial metalloenzymes for enantioselective catalysis based on biotin-avidin.
    Collot J; Gradinaru J; Humbert N; Skander M; Zocchi A; Ward TR
    J Am Chem Soc; 2003 Jul; 125(30):9030-1. PubMed ID: 15369356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial metalloenzymes: (strept)avidin as host for enantioselective hydrogenation by achiral biotinylated rhodium-diphosphine complexes.
    Skander M; Humbert N; Collot J; Gradinaru J; Klein G; Loosli A; Sauser J; Zocchi A; Gilardoni F; Ward TR
    J Am Chem Soc; 2004 Nov; 126(44):14411-8. PubMed ID: 15521760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial metalloenzymes for enantioselective catalysis based on the noncovalent incorporation of organometallic moieties in a host protein.
    Ward TR
    Chemistry; 2005 Jun; 11(13):3798-804. PubMed ID: 15761912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial metalloenzymes based on the biotin-avidin technology: enantioselective catalysis and beyond.
    Ward TR
    Acc Chem Res; 2011 Jan; 44(1):47-57. PubMed ID: 20949947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical optimization of artificial metalloenzymes based on the biotin-avidin technology: (S)-selective and solvent-tolerant hydrogenation catalysts via the introduction of chiral amino acid spacers.
    Skander M; Malan C; Ivanova A; Ward TR
    Chem Commun (Camb); 2005 Oct; (38):4815-7. PubMed ID: 16193124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial transfer hydrogenases based on the biotin-(strept)avidin technology: fine tuning the selectivity by saturation mutagenesis of the host protein.
    Letondor C; Pordea A; Humbert N; Ivanova A; Mazurek S; Novic M; Ward TR
    J Am Chem Soc; 2006 Jun; 128(25):8320-8. PubMed ID: 16787096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial metalloenzymes: proteins as hosts for enantioselective catalysis.
    Thomas CM; Ward TR
    Chem Soc Rev; 2005 Apr; 34(4):337-46. PubMed ID: 15778767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial metalloenzymes for olefin metathesis based on the biotin-(strept)avidin technology.
    Lo C; Ringenberg MR; Gnandt D; Wilson Y; Ward TR
    Chem Commun (Camb); 2011 Nov; 47(44):12065-7. PubMed ID: 21959544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designed evolution of artificial metalloenzymes: protein catalysts made to order.
    Creus M; Ward TR
    Org Biomol Chem; 2007 Jun; 5(12):1835-44. PubMed ID: 17551630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology: Challenges and Opportunities.
    Heinisch T; Ward TR
    Acc Chem Res; 2016 Sep; 49(9):1711-21. PubMed ID: 27529561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Metalloenzymes Based on the Biotin-Streptavidin Technology: Enzymatic Cascades and Directed Evolution.
    Liang AD; Serrano-Plana J; Peterson RL; Ward TR
    Acc Chem Res; 2019 Mar; 52(3):585-595. PubMed ID: 30735358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial metalloenzymes based on biotin-avidin technology for the enantioselective reduction of ketones by transfer hydrogenation.
    Letondor C; Humbert N; Ward TR
    Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4683-7. PubMed ID: 15772162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective Rh-catalyzed hydrogenation of N-formyl dehydroamino esters with monodentate phosphoramidite ligands.
    Panella L; Aleixandre AM; Kruidhof GJ; Robertus J; Feringa BL; de Vries JG; Minnaard AJ
    J Org Chem; 2006 Mar; 71(5):2026-36. PubMed ID: 16496990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemogenetic protein engineering: an efficient tool for the optimization of artificial metalloenzymes.
    Pordea A; Ward TR
    Chem Commun (Camb); 2008 Sep; (36):4239-49. PubMed ID: 18802535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merging the best of two worlds: artificial metalloenzymes for enantioselective catalysis.
    Ringenberg MR; Ward TR
    Chem Commun (Camb); 2011 Aug; 47(30):8470-6. PubMed ID: 21603692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dual anchoring strategy for the localization and activation of artificial metalloenzymes based on the biotin-streptavidin technology.
    Zimbron JM; Heinisch T; Schmid M; Hamels D; Nogueira ES; Schirmer T; Ward TR
    J Am Chem Soc; 2013 Apr; 135(14):5384-8. PubMed ID: 23496309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhodium-catalyzed enantioselective hydrogenation of beta-phthalimide acrylates to synthesis of beta2-amino acids.
    Huang H; Liu X; Deng J; Qiu M; Zheng Z
    Org Lett; 2006 Jul; 8(15):3359-62. PubMed ID: 16836405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counter propagation artificial neural networks modeling of an enantioselectivity of artificial metalloenzymes.
    Mazurek S; Ward TR; Novic M
    Mol Divers; 2007; 11(3-4):141-52. PubMed ID: 18317943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chiral 1-phenylethylamine-derived phosphine-phosphoramidite ligands for highly enantioselective Rh-catalyzed hydrogenation of beta-(acylamino)acrylates: significant effect of substituents on 3,3'-positions of binaphthyl moiety.
    Zhou XM; Huang JD; Luo LB; Zhang CL; Hu XP; Zheng Z
    Org Biomol Chem; 2010 May; 8(10):2320-2. PubMed ID: 20376384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly enantioselective asymmetric hydrogenation of beta-acetamido dehydroamino acid derivatives using a three-hindered quadrant rhodium catalyst.
    Wu HP; Hoge G
    Org Lett; 2004 Sep; 6(20):3645-7. PubMed ID: 15387569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.